UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000038861
Receipt No. R000044309
Scientific Title A study to examine the effects of food intake on relief from eye and nasal discomfort.
Date of disclosure of the study information 2019/12/26
Last modified on 2020/08/05 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A study to examine the effects of food intake on relief from eye and nasal discomfort.
Acronym A study to examine the effects of food intake on relief from eye and nasal discomfort.
Scientific Title A study to examine the effects of food intake on relief from eye and nasal discomfort.
Scientific Title:Acronym A study to examine the effects of food intake on relief from eye and nasal discomfort.
Region
Japan

Condition
Condition Healthy Individuals
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study to examine the effects of improving eye and nasal discomfort by ingesting food derived from Shiikuwasa (Citrus depressa Hayata).
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The Japanese Rhinoconjunctivitis Quality of Life Questionnaire version 2002 (JRQLQ No1)
Key secondary outcomes Assessment of the nasal cavity

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation NO
Institution consideration
Blocking YES
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 The foods that are contained nobiletin and tangeretin
Interventions/Control_2 Placebo
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
49 years-old >=
Gender Male and Female
Key inclusion criteria 1. Male and female aged 20 to 49
2. Persons who have perennial allergies or seasonal allergies as subjective symptoms
3. Persons who can obtain consent for voluntary study participation in writing
4. Persons who are not ill
Key exclusion criteria 1. Persons who regularly consume yogurt or lactic acid bacteria food (more than 4 times a week)
2. Persons who regularly consume citrus fruits and processed foods (at least 4 times a week)
3. Participants in foods and health foods that are described as containing nobiletin and tangeretin
4. Persons who must continue to use drugs that may affect nose and eye symptoms (antiallergic drugs, antihistamines, steroidal vasoconstrictors, antihypertensive drugs, etc.)
6. Persons who may develop allergies to the test foods.
7. Persons who are judged to be inappropriate as subjects from the results of the lifestyle questionnaire
8. Participants in other clinical studies at the start of this study
9. Persons who are pregnant or breastfeeding during the study period
10. A person who is judged unsuitable for study participation by the investigator
Target sample size 34

Research contact person
Name of lead principal investigator
1st name YUTAKA
Middle name
Last name OGIDOH
Organization Okinawa TLO Co., Ltd.
Division name Not Division
Zip code 903-0213
Address University of the Ryukyus - Industry-academia-government collaboration building 3F
TEL 098-895-1701
Email ogidoh@okinawa-tlo.com

Public contact
Name of contact person
1st name YUTAKA
Middle name
Last name OGIDOH
Organization Okinawa TLO Co., Ltd.
Division name Not Division
Zip code 903-0213
Address University of the Ryukyus - Industry-academia-government collaboration building 3F
TEL 098-895-1701
Homepage URL
Email ogidoh@okinawa-tlo.com

Sponsor
Institute Okinawa TLO Co., Ltd.
Institute
Department

Funding Source
Organization Okinawa TLO Co., Ltd.
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Brain Care Clinic Ethics Review Committee
Address Samon-Cho 13, Isobe Build. 2F, Shinjyuku-ku, Tokyo
Tel 06-6882-1130
Email ethics_board@drc-web.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions いきいきクリニック(大阪府)

Other administrative information
Date of disclosure of the study information
2019 Year 12 Month 26 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 34
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 10 Month 30 Day
Date of IRB
2019 Year 11 Month 22 Day
Anticipated trial start date
2019 Year 12 Month 20 Day
Last follow-up date
2020 Year 03 Month 10 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 12 Month 12 Day
Last modified on
2020 Year 08 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044309